We are live on
!
Find out more
AC
Amia Capital Portfolio holdings
AUM
$32.1M
1-Year Est. Return
0.56%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.1M
AUM Growth
-$35.6M
(-29%)
Cap. Flow
-$31.4M
Cap. Flow
% of AUM
-36.45%
Top 10 Holdings %
Top 10 Hldgs %
85.07%
Holding
39
New
1
Increased
10
Reduced
24
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$6.18M |
| 2 |
Petrobras
PBR
|
+$2.12M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
+$223K |
| 4 |
Fate Therapeutics
FATE
|
+$118K |
| 5 |
Black Diamond Therapeutics
BDTX
|
+$82.3K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.91% |
| 2 | Materials | 11.06% |
| 3 | Energy | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRFS
1
Grifois
GRFS
$5.18B
| $22.5M | 26.12% |
1,295,478
-281,819
| -18% | -$4.98M |
|
|
LSXMK
2
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $12.2M | 14.14% |
474,803
-250,335
| -35% | -$6.78M |
|
|
LSXMA
3
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $11.7M | 13.64% |
481,627
-262,321
| -35% | -$6.75M |
|
|
4
Vale
VALE
$60B
| $9.52M | 11.06% |
900,000
+550,000
| +157% | +$6.18M |
|
|
5
Petrobras
PBR
$119B
| $9.26M | 10.76% |
1,300,000
+250,000
| +24% | +$2.12M |
|
6
Ionis Pharmaceuticals
IONS
$8.75B
| $2.02M | 2.35% |
42,552
-2,647
| -6% | -$147K |
|
|
BBL
7
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1.7M | 1.98% |
39,933
-387,763
| -91% | -$17.3M |
|
8
Neurocrine Biosciences
NBIX
$17.4B
| $1.53M | 1.78% |
15,939
-2,360
| -13% | -$273K |
|
9
Incyte
INCY
$23.1B
| $1.43M | 1.66% |
15,939
-3,853
| -19% | -$372K |
|
10
Vertex Pharmaceuticals
VRTX
$122B
| $1.37M | 1.59% |
5,026
-2,325
| -32% | -$641K |
|
11
argenx
ARGX
$52.9B
| $1.33M | 1.55% |
5,077
-239
| -4% | -$57.5K |
|
12
Moderna
MRNA
$23.7B
| $1.25M | 1.45% |
17,607
-4,441
| -20% | -$310K |
|
13
Alnylam Pharmaceuticals
ALNY
$36.4B
| $1.01M | 1.17% |
6,937
-2,467
| -26% | -$351K |
|
14
Halozyme
HALO
$9.14B
| $953K | 1.11% |
36,279
-9,655
| -21% | -$269K |
|
|
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $878K | 1.02% |
6,437
-672
| -9% | -$71.4K |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals
ALXN
| $808K | 0.94% |
7,061
-386
| -5% | -$41.6K |
|
17
Agios Pharmaceuticals
AGIO
$2.38B
| $761K | 0.88% |
21,740
-356
| -2% | -$15.6K |
|
|
ESPR
18
DELISTED
Esperion Therapeutics
ESPR
| $761K | 0.88% |
20,464
-439
| -2% | -$17.4K |
|
19
MacroGenics
MGNX
$275M
| $608K | 0.71% |
24,131
-1,272
| -5% | -$34.7K |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $512K | 0.59% |
19,972
-5,630
| -22% | -$128K |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $467K | 0.54% |
7,644
+447
| +6% | +$22.7K |
|
|
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
| $440K | 0.51% |
38,841
+290
| +0.8% | +$3.58K |
|
|
23
Fate Therapeutics
FATE
$330M
| $408K | 0.47% |
10,209
+3,371
| +49% | +$118K |
|
24
Exelixis
EXEL
$14B
| $378K | 0.44% |
15,479
-464
| -3% | -$10.8K |
|
25
CRISPR Therapeutics
CRSP
$4.74B
| $366K | 0.43% |
4,374
+272
| +7% | +$24.1K |
|
Similar funds
QI
SAM
FCMI
AG
NLG
BEVI
BGDR
TAAM
Amia Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Amia Capital held 39 positions worth $86.1M, down 29% from $122M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Amia Capital withdrew a net $31.4M in Q3 2020, closing 4 positions and reducing 24 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $686K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Materials and Energy.
Against the trend, Amia Capital opened a new position in Molecular Templates, Inc. worth $205K.
- Amia Capital's largest Q3 2020 buy was Molecular Templates, Inc.: 1,254 shares worth $205K.
- Amia Capital added most to Vale in Q3 2020, an estimated $6.18M increase.
- Amia Capital's biggest Q3 2020 reduction was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares), cutting an estimated $17.3M.
- Amia Capital fully exited iShares Biotechnology ETF in Q3 2020, selling an estimated $686K.
- Amia Capital's ten largest holdings make up 85% of its $86.1M portfolio in Q3 2020.
- Amia Capital opened 1 new position and closed 4 in Q3 2020.
- Amia Capital's portfolio value fell 29% quarter-over-quarter to $86.1M.
Based on Amia Capital's 13F filing for Q3 2020, filed 16 Nov 2020.